Menu
GeneBe

MYO5B

myosin VB, the group of Myosin heavy chains, class V|MicroRNA protein coding host genes

Basic information

Region (hg38): 18:49822788-50195164

Links

ENSG00000167306NCBI:4645OMIM:606540HGNC:7603Uniprot:Q9ULV0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • microvillus inclusion disease (Definitive), mode of inheritance: AR
  • microvillus inclusion disease (Strong), mode of inheritance: AR
  • microvillus inclusion disease (Supportive), mode of inheritance: AR
  • progressive familial intrahepatic cholestasis type 1 (Supportive), mode of inheritance: AR
  • microvillus inclusion disease (Strong), mode of inheritance: AR
  • cholestasis, progressive familial intrahepatic, 10 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Diarrhea 2, with microvillus atrophy, with or without cholestasis; Cholestasis, progressive familial intrahepatic 10ARGastrointestinal; RenalIndividuals with Diarrhea 2, with microvillus atrophy, with or without cholestasis may require nutritional support with parenteral nutrition; Renal fanconi syndrome has been described, and appropriate care of related sequelae may be beneficial; Individuals with progressive familial intrahepatic cholestasis 10 or with cholestasis as part of Diarrhea 2, with microvillus atrophy. with or without cholestasis may benefit from medical management (eg, with ursodeoxycholic acid), but may require surgical intervention (eg, with biliary diversion); Liver transplant has been describedGastrointestinal; Renal16800870; 19006234; 18724368; 21199752; 20186687; 22030065; 21206382; 22441677; 27532546; 28027573; 32304554; 33525641

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYO5B gene.

  • not provided (1052 variants)
  • Congenital microvillous atrophy (348 variants)
  • Inborn genetic diseases (76 variants)
  • Diarrhea with Microvillus Atrophy (18 variants)
  • not specified (16 variants)
  • MYO5B-related condition (13 variants)
  • Congenital microvillous atrophy;Cholestasis, progressive familial intrahepatic, 10 (6 variants)
  • Cholestasis, progressive familial intrahepatic, 10 (5 variants)
  • Cholestasis, progressive familial intrahepatic, 10;Congenital microvillous atrophy (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYO5B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
11
clinvar
211
clinvar
15
clinvar
237
missense
2
clinvar
4
clinvar
465
clinvar
19
clinvar
17
clinvar
507
nonsense
16
clinvar
1
clinvar
2
clinvar
19
start loss
0
frameshift
10
clinvar
3
clinvar
13
inframe indel
5
clinvar
1
clinvar
6
splice donor/acceptor (+/-2bp)
1
clinvar
5
clinvar
1
clinvar
7
splice region
1
28
27
3
59
non coding
153
clinvar
118
clinvar
145
clinvar
416
Total 29 13 637 348 178

Highest pathogenic variant AF is 0.0000263

Variants in MYO5B

This is a list of pathogenic ClinVar variants found in the MYO5B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-49822831-T-C Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)888645
18-49822927-G-A Congenital microvillous atrophy Uncertain significance (Mar 30, 2018)888646
18-49823043-A-G Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)888647
18-49823048-C-A Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)888648
18-49823080-T-C Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890347
18-49823090-C-G Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)890348
18-49823092-T-G Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890349
18-49823103-C-G Congenital microvillous atrophy Benign (Jan 13, 2018)326920
18-49823106-A-G Congenital microvillous atrophy Uncertain significance (Jan 15, 2018)890350
18-49823107-T-C Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890351
18-49823114-C-T Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890352
18-49823120-T-G Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)890353
18-49823129-G-C Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)890910
18-49823130-A-G Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890911
18-49823132-A-ACTTT Diarrhea with Microvillus Atrophy Uncertain significance (Jun 14, 2016)326921
18-49823154-G-A Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)326922
18-49823156-A-G Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)326923
18-49823171-T-C Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)890912
18-49823176-A-AT Diarrhea with Microvillus Atrophy Uncertain significance (Jun 14, 2016)326924
18-49823179-A-G Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890913
18-49823189-C-T Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890914
18-49823198-C-G Congenital microvillous atrophy Uncertain significance (Jan 12, 2018)890915
18-49823198-C-T Congenital microvillous atrophy Benign (Jan 12, 2018)326925
18-49823232-T-C Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)892147
18-49823251-G-A Congenital microvillous atrophy Uncertain significance (Jan 13, 2018)892148

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYO5Bprotein_codingprotein_codingENST00000285039 40372281
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.38e-231.0012473501121248470.000449
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.61610519961.050.000064512201
Missense in Polyphen353385.140.916554693
Synonymous-1.684403971.110.00002533415
Loss of Function4.135396.90.5470.000004831186

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001140.00113
Ashkenazi Jewish0.0003980.000397
East Asian0.001110.00106
Finnish0.0002330.000232
European (Non-Finnish)0.0003620.000362
Middle Eastern0.001110.00106
South Asian0.0005560.000556
Other0.0004950.000494

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation. Required in a complex with RAB11A and RAB11FIP2 for the transport of NPC1L1 to the plasma membrane. Together with RAB11A participates in CFTR trafficking to the plasma membrane and TF (transferrin) recycling in nonpolarized cells. Together with RAB11A and RAB8A participates in epithelial cell polarization. Together with RAB25 regulates transcytosis. {ECO:0000269|PubMed:21206382, ECO:0000269|PubMed:21282656}.;
Disease
DISEASE: Diarrhea 2, with microvillus atrophy (DIAR2) [MIM:251850]: A disease characterized by onset of intractable life-threatening watery diarrhea during infancy. Two forms are recognized: early-onset microvillus inclusion disease with diarrhea beginning in the neonatal period, and late-onset, with first symptoms appearing after 3 or 4 months of life. {ECO:0000269|PubMed:18724368, ECO:0000269|PubMed:19006234, ECO:0000269|PubMed:20186687, ECO:0000269|PubMed:21206382, ECO:0000269|PubMed:24138727, ECO:0000269|PubMed:24892806}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.180

Intolerance Scores

loftool
0.0862
rvis_EVS
-0.37
rvis_percentile_EVS
28.21

Haploinsufficiency Scores

pHI
0.247
hipred
Y
hipred_score
0.706
ghis
0.501

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.668

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Myo5b
Phenotype
homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; digestive/alimentary phenotype;

Zebrafish Information Network

Gene name
myo5b
Affected structure
enterocyte
Phenotype tag
abnormal
Phenotype quality
columnar

Gene ontology

Biological process
renal water homeostasis;protein transport;vesicle-mediated transport;endosomal transport
Cellular component
myosin complex;cytoplasmic vesicle membrane;protein-containing complex;apical cortex;recycling endosome;extracellular exosome
Molecular function
microfilament motor activity;protein binding;calmodulin binding;ATP binding;Rab GTPase binding;actin filament binding